Q: What is Humira used for?

Humira is used to treat: Rheumatoid arthritis Juvenile idiopathic arthritis Psoriatic arthritis and others.

Q: How does Humira work?

Targeting Inflammation Humira belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the body's immune system. While it normally helps the body fight infections, people with certain autoimmune diseases produce too much of it, leading to chronic inflammation. How Adalimumab Works The active ingredient in Humira, adalimumab, is a monoclonal antibody. It is designed to recognize and bind to TNF-alpha proteins in the blood and tissues. By attaching to these proteins, the medication prevents them from connecting to receptors on healthy cells and triggering the inflammatory response. Effects on the Body By reducing the activity of TNF, Humira helps to manage symptoms and prevent long-term damage. Its primary actions include: Decreasing swelling and pain in the joints. Reducing skin inflammation and the formation of plaques. Lowering inflammation in the digestive tract. Slowing or preventing permanent damage to bones and cartilage. Because this medication works by suppressing a specific part of the immune system to control inflammation, it may also affect the body's natural ability to fight off certain types of infections.

Q: What are the active ingredients in Humira?

The active ingredient in Humira is adalimumab .

Q: What are the side effects of Humira?

Common side effects of Humira may include: injection site reactions upper respiratory infection headache Always consult with a healthcare professional about potential side effects.

Q: What drug class is Humira?

Humira belongs to the TNF inhibitor drug class.

Q: What is the dosage of Humira and how do I take it?

How to Use Humira Humira is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is available as a prefilled syringe or an injection pen. Patients or caregivers can often be trained to perform the injections at home. Injection Sites The recommended areas for injection are the front of the thighs or the abdomen. When injecting into the abdomen, avoid the area within two inches of the navel. It is important to rotate injection sites each time a dose is given, choosing a spot at least one inch away from the previous injection site. Preparation Remove the medication from the refrigerator and allow it to reach room temperature for 15 to 30 minutes before injecting. Do not attempt to warm it using a microwave or hot water. Check the liquid through the viewing window. It should be clear and colorless. Do not use the medication if it is cloudy, discolored, or contains flakes or particles. Do not shake the syringe or pen, as this can damage the medication. Do not remove the cap until you are ready to inject. Administration Tips Clean the injection site with an alcohol swab and let it dry. Do not inject into skin that is sore, bruised, red, scarred, or hard. Follow the specific instructions provided with your device regarding how to pinch the skin and trigger the injection. Missed Dose If you miss a dose of Humira, take it as soon as you remember. Take your next dose at your regular scheduled time. Do not use extra medicine to make up for a missed dose.

Q: Is Humira safe during pregnancy and breastfeeding?

Pregnancy Research on the use of Humira during pregnancy is ongoing. Current evidence suggests that the medication does not appear to increase the risk of major birth defects. However, adalimumab (the active ingredient in Humira) can cross the placenta, particularly during the third trimester. This exposure could potentially affect the immune system of the newborn. If you use Humira during pregnancy, it is important to inform your child's pediatrician. The timing of certain vaccinations, especially live vaccines like the rotavirus vaccine, may need to be delayed for the infant to ensure their immune system can respond safely. Breastfeeding Humira is known to pass into breast milk in very small amounts. Because adalimumab is a large protein molecule, it is generally believed that most of the drug is broken down in the infant's digestive system before it can be absorbed into their bloodstream. Most clinical experts consider breastfeeding while taking Humira to be low risk, but you should discuss your specific situation with your doctor. Clinical Consultation If you are pregnant, planning to become pregnant, or breastfeeding, talk to your healthcare team about: The severity of your condition and the risks of stopping treatment. The potential effects of the medication on the developing fetus or nursing infant. The timing of infant vaccinations if the drug was used during the third trimester.

Q: What is the FDA approval status of Humira?

FDA Approval and Indications Humira (adalimumab) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various autoimmune and inflammatory disorders. These include rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and certain types of uveitis. Boxed Warning The FDA requires a boxed warning for Humira due to the risk of serious infections and malignancy. This is the most serious type of warning issued by the FDA. Serious Infections: Patients taking Humira are at an increased risk for developing serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, and invasive fungal infections. Malignancy: Lymphoma and other cancers, some fatal, have been reported in children and adolescent patients treated with TNF blockers like Humira. A rare type of cancer called hepatosplenic T-cell lymphoma has occurred in young adults with inflammatory bowel disease using these medications. Regulatory Monitoring The FDA monitors the safety of Humira through post-marketing surveillance. Healthcare providers are required to screen patients for tuberculosis and other infections before starting treatment and monitor them closely during therapy for signs of infection or unusual growths.

Question 1

What is Humira?

Accepted Answer

Humira is a medication that belongs to a class of drugs called tumor necrosis factor (TNF) blockers. It works by targeting and neutralizing a specific protein in the body that contributes to inflammation.

As a monoclonal antibody, this therapy helps to regulate the immune system's response. By interfering with the inflammatory process, it helps to reduce the physical effects of overactive immune activity.

Question 2

What is Humira used for?

Accepted Answer

Humira is used to treat:

Rheumatoid arthritis
Juvenile idiopathic arthritis
Psoriatic arthritis
and others.

Question 3

How does Humira work?

Accepted Answer

Targeting Inflammation

Humira belongs to a class of drugs known as tumor necrosis factor (TNF) blockers. TNF is a protein naturally produced by the body's immune system. While it normally helps the body fight infections, people with certain autoimmune diseases produce too much of it, leading to chronic inflammation.

How Adalimumab Works

The active ingredient in Humira, adalimumab, is a monoclonal antibody. It is designed to recognize and bind to TNF-alpha proteins in the blood and tissues. By attaching to these proteins, the medication prevents them from connecting to receptors on healthy cells and triggering the inflammatory response.

Effects on the Body

By reducing the activity of TNF, Humira helps to manage symptoms and prevent long-term damage. Its primary actions include:

Decreasing swelling and pain in the joints.
Reducing skin inflammation and the formation of plaques.
Lowering inflammation in the digestive tract.
Slowing or preventing permanent damage to bones and cartilage.

Because this medication works by suppressing a specific part of the immune system to control inflammation, it may also affect the body's natural ability to fight off certain types of infections.

Question 4

What are the active ingredients in Humira?

Accepted Answer

The active ingredient in Humira is adalimumab.

Question 5

What are the side effects of Humira?

Accepted Answer

Common side effects of Humira may include:

injection site reactions
upper respiratory infection
headache

Always consult with a healthcare professional about potential side effects.

Question 6

What drug class is Humira?

Accepted Answer

Humira belongs to the TNF inhibitor drug class.

Question 7

What is the dosage of Humira and how do I take it?

Accepted Answer

How to Use Humira

Humira is given as a subcutaneous injection, which means it is injected into the fatty tissue just under the skin. It is available as a prefilled syringe or an injection pen. Patients or caregivers can often be trained to perform the injections at home.

Injection Sites

The recommended areas for injection are the front of the thighs or the abdomen. When injecting into the abdomen, avoid the area within two inches of the navel. It is important to rotate injection sites each time a dose is given, choosing a spot at least one inch away from the previous injection site.

Preparation

Remove the medication from the refrigerator and allow it to reach room temperature for 15 to 30 minutes before injecting. Do not attempt to warm it using a microwave or hot water.
Check the liquid through the viewing window. It should be clear and colorless. Do not use the medication if it is cloudy, discolored, or contains flakes or particles.
Do not shake the syringe or pen, as this can damage the medication.
Do not remove the cap until you are ready to inject.

Administration Tips

Clean the injection site with an alcohol swab and let it dry. Do not inject into skin that is sore, bruised, red, scarred, or hard. Follow the specific instructions provided with your device regarding how to pinch the skin and trigger the injection.

Missed Dose

If you miss a dose of Humira, take it as soon as you remember. Take your next dose at your regular scheduled time. Do not use extra medicine to make up for a missed dose.

Question 8

Is Humira safe during pregnancy and breastfeeding?

Accepted Answer

Pregnancy

Research on the use of Humira during pregnancy is ongoing. Current evidence suggests that the medication does not appear to increase the risk of major birth defects. However, adalimumab (the active ingredient in Humira) can cross the placenta, particularly during the third trimester. This exposure could potentially affect the immune system of the newborn.

If you use Humira during pregnancy, it is important to inform your child's pediatrician. The timing of certain vaccinations, especially live vaccines like the rotavirus vaccine, may need to be delayed for the infant to ensure their immune system can respond safely.

Breastfeeding

Humira is known to pass into breast milk in very small amounts. Because adalimumab is a large protein molecule, it is generally believed that most of the drug is broken down in the infant's digestive system before it can be absorbed into their bloodstream. Most clinical experts consider breastfeeding while taking Humira to be low risk, but you should discuss your specific situation with your doctor.

Clinical Consultation

If you are pregnant, planning to become pregnant, or breastfeeding, talk to your healthcare team about:

The severity of your condition and the risks of stopping treatment.
The potential effects of the medication on the developing fetus or nursing infant.
The timing of infant vaccinations if the drug was used during the third trimester.

Question 9

What forms and strengths does Humira come in?

Accepted Answer

Humira is supplied as a sterile, preservative-free solution for injection under the skin. It is available in the following delivery systems:

Single-dose pre-filled pen: Designed for self-administration, this device automates the injection process.
Single-dose pre-filled syringe: A syringe with a fixed needle, used for manual injection by a patient, caregiver, or healthcare provider.
Single-dose vial: A glass vial containing the solution, intended for use with a separate syringe, often used in clinical settings or for specific pediatric needs.

Question 10

What is the FDA approval status of Humira?

Accepted Answer

FDA Approval and Indications

Humira (adalimumab) is approved by the U.S. Food and Drug Administration (FDA) for the treatment of various autoimmune and inflammatory disorders. These include rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and certain types of uveitis.

Boxed Warning

The FDA requires a boxed warning for Humira due to the risk of serious infections and malignancy. This is the most serious type of warning issued by the FDA.

Serious Infections: Patients taking Humira are at an increased risk for developing serious infections that may lead to hospitalization or death. These include tuberculosis (TB), bacterial sepsis, and invasive fungal infections.
Malignancy: Lymphoma and other cancers, some fatal, have been reported in children and adolescent patients treated with TNF blockers like Humira. A rare type of cancer called hepatosplenic T-cell lymphoma has occurred in young adults with inflammatory bowel disease using these medications.

Regulatory Monitoring

The FDA monitors the safety of Humira through post-marketing surveillance. Healthcare providers are required to screen patients for tuberculosis and other infections before starting treatment and monitor them closely during therapy for signs of infection or unusual growths.

Question 11

What should I know about Humira and cost?

Accepted Answer

Factors Influencing Cost

Several factors determine the final price a patient pays for Humira:

Insurance Coverage: Most commercial insurance plans and Medicare Part D cover Humira, though it is often placed on a higher specialty tier requiring a significant co-pay or coinsurance.
Prior Authorization: Insurance companies typically require a prior authorization process, where a healthcare provider must justify the medical necessity of the drug before coverage is approved.
Pharmacy Choice: Humira is a specialty medication and is usually dispensed through specialty pharmacies rather than standard retail locations.

Financial Assistance and Savings

To help manage out-of-pocket expenses, several programs may be available:

Co-pay Cards: The manufacturer offers a savings card for patients with commercial (private) insurance, which can significantly reduce monthly costs for eligible individuals.
Patient Assistance Programs: For individuals without insurance or those who meet specific income requirements, manufacturer-sponsored patient assistance programs may provide the medication at no cost.
Biosimilars: Several FDA-approved biosimilars for adalimumab are available. These medications are highly similar to Humira and may be offered at a lower price point depending on the insurance formulary.

Patients are encouraged to contact their insurance provider and the manufacturer to explore the most current pricing and assistance options available to them.

Humira

📋Overview

How It Works

Uses

Active Ingredients

Common Side Effects

Warnings & Precautions

Dosage

Pregnancy & Breastfeeding

Frequently Asked Questions

📚References

Found an Error?

Find Discounts for Humira

Hospitals.net Disclosure